146 related articles for article (PubMed ID: 32283709)
1. A Unique Gene-Silencing Approach, Using an Intelligent RNA Expression Device (iRed), Results in Minimal Immune Stimulation When Given by Local Intrapleural Injection in Malignant Pleural Mesothelioma.
Ando H; Saito-Tarashima N; Lila ASA; Kinjo N; Shimizu T; Ishima Y; Minakawa N; Ishida T
Molecules; 2020 Apr; 25(7):. PubMed ID: 32283709
[TBL] [Abstract][Full Text] [Related]
2. Gene Silencing Using 4'-thioDNA as an Artificial Template to Synthesize Short Hairpin RNA Without Inducing a Detectable Innate Immune Response.
Tarashima N; Ando H; Kojima T; Kinjo N; Hashimoto Y; Furukawa K; Ishida T; Minakawa N
Mol Ther Nucleic Acids; 2016 Jan; 5(1):e274. PubMed ID: 26730811
[TBL] [Abstract][Full Text] [Related]
3. Systemically Administered RNAi Molecule Sensitizes Malignant Pleural Mesotheliomal Cells to Pemetrexed Therapy.
Abu Lila AS; Fukushima M; Huang CL; Wada H; Ishida T
Mol Pharm; 2016 Nov; 13(11):3955-3963. PubMed ID: 27740765
[TBL] [Abstract][Full Text] [Related]
4. An RNAi therapeutic, DFP-10825, for intraperitoneal and intrapleural malignant cancers.
Ando H; Ishida T
Adv Drug Deliv Rev; 2020; 154-155():27-36. PubMed ID: 32781056
[TBL] [Abstract][Full Text] [Related]
5. Systemic delivery of Eg5 shRNA-expressing plasmids using PEGylated DC-Chol/DOPE cationic liposome: Long-term silencing and anticancer effects in vivo.
Seraj S; Lee J; Ahn HJ
Biochem Pharmacol; 2019 Aug; 166():192-202. PubMed ID: 31129050
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of thymidylate synthase by RNAi molecules enhances the antitumor effect of pemetrexed in an orthotopic malignant mesothelioma xenograft mouse model.
Abu Lila AS; Kato C; Fukushima M; Huang CL; Wada H; Ishida T
Int J Oncol; 2016 Apr; 48(4):1399-407. PubMed ID: 26847426
[TBL] [Abstract][Full Text] [Related]
7. Advanced therapeutic approach for the treatment of malignant pleural mesothelioma via the intrapleural administration of liposomal pemetrexed.
Ando H; Kobayashi S; Abu Lila AS; Eldin NE; Kato C; Shimizu T; Ukawa M; Kawazoe K; Ishida T
J Control Release; 2015 Dec; 220(Pt A):29-36. PubMed ID: 26476173
[TBL] [Abstract][Full Text] [Related]
8. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
9. Anticancer activity of the intraperitoneal-delivered DFP-10825, the cationic liposome-conjugated RNAi molecule targeting thymidylate synthase, on peritoneal disseminated ovarian cancer xenograft model.
Iizuka K; Jin C; Eshima K; Hong MH; Eshima K; Fukushima M
Drug Des Devel Ther; 2018; 12():673-683. PubMed ID: 29636601
[TBL] [Abstract][Full Text] [Related]
10. [Chemical Approaches for RNAi Drug Development].
Saito-Tarashima N
Yakugaku Zasshi; 2020; 140(10):1259-1268. PubMed ID: 32999205
[TBL] [Abstract][Full Text] [Related]
11. The novel functional nucleic acid iRed effectively regulates target genes following cytoplasmic delivery by faint electric treatment.
Hasan M; Tarashima N; Fujikawa K; Ohgita T; Hama S; Tanaka T; Saito H; Minakawa N; Kogure K
Sci Technol Adv Mater; 2016; 17(1):554-562. PubMed ID: 27877903
[TBL] [Abstract][Full Text] [Related]
12. RNA interference-mediated silencing of focal adhesion kinase inhibits growth of human malignant glioma xenograft in nude mice.
Wang GJ; Ma YP; Yang Y; Zhang N; Wang W; Liu SY; Chen LJ; Jiang Y; Zhao X; Wei YQ; Deng HX
Cell Biol Int; 2011 Aug; 35(8):841-8. PubMed ID: 21247411
[TBL] [Abstract][Full Text] [Related]
13. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
14. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
Gu J; Fang X; Hao J; Sha X
Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of RNA interference mediated by cationic liposomes].
Han W; Zhen Y; Zhang S; Zhao Y; Sun Y; Guo X; Wang E; Liu Z; Sun Y
Sheng Wu Gong Cheng Xue Bao; 2015 Aug; 31(8):1239-46. PubMed ID: 26762045
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Pharmacogenomic Profiling of Malignant Pleural Mesothelioma Identifies a Subgroup Sensitive to FGFR Inhibition.
Quispel-Janssen JM; Badhai J; Schunselaar L; Price S; Brammeld J; Iorio F; Kolluri K; Garnett M; Berns A; Baas P; McDermott U; Neefjes J; Alifrangis C
Clin Cancer Res; 2018 Jan; 24(1):84-94. PubMed ID: 29061644
[No Abstract] [Full Text] [Related]
17. Effects of sucrose ester structures on liposome-mediated gene delivery.
Zhao Y; Liu A; Du Y; Cao Y; Zhang E; Zhou Q; Hai H; Zhen Y; Zhang S
Acta Biomater; 2018 May; 72():278-286. PubMed ID: 29609051
[TBL] [Abstract][Full Text] [Related]
18. miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma.
Williams M; Kirschner MB; Cheng YY; Hanh J; Weiss J; Mugridge N; Wright CM; Linton A; Kao SC; Edelman JJ; Vallely MP; McCaughan BC; Cooper W; Klebe S; Lin RC; Brahmbhatt H; MacDiarmid J; van Zandwijk N; Reid G
Oncotarget; 2015 Sep; 6(27):23480-95. PubMed ID: 26125439
[TBL] [Abstract][Full Text] [Related]
19. Prolonged retention of liposomes in the pleural cavity of normal mice and high tumor distribution in mice with malignant pleural effusion, after intrapleural injection.
Marazioti A; Papadia K; Giannou A; Stathopoulos GT; Antimisiaris SG
Int J Nanomedicine; 2019; 14():3773-3784. PubMed ID: 31213801
[No Abstract] [Full Text] [Related]
20. Intracellular lactate-mediated induction of estrogen receptor beta (ERĪ²) in biphasic malignant pleural mesothelioma cells.
Manente AG; Pinton G; Zonca S; Cilli M; Rinaldi M; Daga A; Nilsson S; Moro L
Oncotarget; 2015 Sep; 6(28):25121-34. PubMed ID: 26208479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
